THNR vs. OZEM ETF Comparison

Comparison of Amplify Weight Loss Drug & Treatment ETF (THNR) to Roundhill GLP-1 & Weight Loss ETF (OZEM)

THNR

Amplify Weight Loss Drug & Treatment ETF

THNR Description

The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.

Grade (RS Rating)

Last Trade

$25.89

Average Daily Volume

10,960

Number of Holdings ^*

* may have additional holdings in another (foreign) market

OZEM

Roundhill GLP-1 & Weight Loss ETF

OZEM Description

OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.

Grade (RS Rating)

Last Trade

$26.53

Average Daily Volume

75,803

Number of Holdings ^*

* may have additional holdings in another (foreign) market

Performance

Period	THNR	OZEM
30 Days	1.44%	3.59%
60 Days
90 Days
12 Months

3 Overlapping Holdings

Symbol	Grade	Weight in THNR	Weight in OZEM	Overlap
AMGN	B	5.57%	4.2%	4.2%
LLY	B	15.58%	21.39%	15.58%
NVO	C	14.9%	20.52%	14.9%

THNR Overweight 4 Positions Relative to OZEM

Symbol	Grade	Weight
PFE	D	5.32%
MRK	C	5.02%
CTLT	B	4.75%
TMO	D	4.72%

THNR Underweight 4 Positions Relative to OZEM

Symbol	Grade	Weight
ALT	F	-3.97%
TERN	C	-3.32%
VKTX	D	-3.27%
GPCR	F	-3.14%

THNR: Top Represented Industries & Keywords

Industries: Drug Manufacturers - Major Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic

OZEM: Top Represented Industries & Keywords

Industries: Biotechnology Drug Manufacturers - Major